Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune disease

Abstract Severe cholestatic disease and hyperlipidemia are both commonly encountered by medical professionals. This article reviews the current pathophysiological model of lipoprotein-X syndrome related to 3 cases from 2 academic medical centers in the United States.